|
Re: Cured?
There isn't one formula for this that fits us all.
HER2's are a somewhat younger group than the group with common bc. The more risk factors one has and the younger one is at the time of diagnosis, the longer and more intensively one should be monitored because the treatments are less likely to be effective for that age group.
Herceptin has changed things to some degree, but the common use of it is still so recent that they are still acquiring the information about recurrence and time intervals for that.
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
|
Threaded Mode